Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syngenta commences bid for Devgen

Syngenta has commenced its tender offer for all outstanding shares and warrants in Belgian biotechnology company Devgen (Ghent). The Swiss company announced its intention in September to bid €16 ($20 at the current rate) a share ( Agrow No 649, p 3). The bid has been recommended by the board of directors of Devgen and is supported by a number of major shareholders holding approximately 48% of shares, Syngenta says. It has been approved by the Belgian Financial Services and Markets Authority. The acceptance period for the tender offer opens on November 14th and is scheduled to close on December 5th. The results of the tender offer will be published on December 12th and, if the offer is successful, settlement will take place on December 17th. Devgen is listed on the NYSE Euronext Brussels exchange and delisting is planned on completion of the transaction.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG006891

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel